Gold prices have leaped after the Federal Reserve has cut interest rates by a double-dose of 50 basis points in a shock move to tackle the evolving risk of coronavirus. The disease has taken the lives of some 3,000 people, six of them in the US. It has already infected some 90,000 worldwide. The illness has caused massive disruptions to supply chains.
XAU/USD is on the rise as lower US yields make the precious metal more attractive. The yellow metal carries no yield.
Resistance awaits at $1,630, followed by $1,660, and then the peak of $1,689 high which is the seven-year high.
The Relative Strength Index on the four-hour chart is below 70, allowing for more gains. Momentum is to the downside – but it is waning and may turn soon. Just above the $1,630 level, we see the 200 Simple Moving Average. Overcoming that level is critical for further gains.
more to come
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.